Although some human antibodies seem to cross-react with canine epitopes, for example, antibodies to HER-2 for osteosarcoma (16) and CSPG4 for melanoma (17), a single amino acid sequence in a critical position can prevent cross-species reactivity as documented in the case of rituximab. This evidence concerns the gene ERBB2 and osteosarcoma.